ABT vs NVDA: Which Stock is Better?
Side-by-side comparison of Abbott Laboratories and Nvidia Corp in 2026
Comparison Updated:
ABT
Abbott Laboratories
$0.00
NVDA
Nvidia Corp
$184.94
Key Metrics Comparison
| Metric | ABT | NVDA | Winner |
|---|---|---|---|
| Market Cap | $0.00M | $4.49T | NVDA |
| P/E Ratio | N/A | N/A | Tie |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze ABT
Full quant analysis
Analyze NVDA
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ABT or NVDA a better investment?
Comparing ABT and NVDA: Abbott Laboratories has a market cap of $0.00M while Nvidia Corp has $4.49T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ABT and NVDA?
ABT (Abbott Laboratories) and NVDA (Nvidia Corp) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ABT or NVDA?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.